ScreenerHero

SUPN Supernus Pharmaceuticals, Inc. - Common Stock

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · supernus.com
42.57USD+0.45%Mkt Cap: 2.47B $P/E: —

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap2.47B USD
Enterprise Value2.13B USD
Revenue (TTM)830.44M USD
Gross Profit644.39M USD
Net Income (TTM)-38.55M USD
Revenue/Share14.46 USD
Last Price42.57 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees778
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)9.50
PEG—
EV/EBITDA19.30
EV/Revenue2.57
P/S2.97
P/B2.39
EPS (TTM)-1.92
EPS (Forward)4.46
52W Range
40.7510% of range59.68
52W High59.68 USD
52W Low40.75 USD
Profitability
Gross Margin89.63%
Oper. Margin-2.48%
EBITDA Margin13.30%
Profit Margin-5.36%
ROE-3.63%
ROA-2.65%
Growth
Revenue Growth32.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF47.33M USD
CapEx (TTM)1.34M USD
FCF Margin10.19%
FCF Yield3.43%
Net Debt-331.90M USD
Net Debt/EBITDA-3.01
Balance Sheet
Debt/Equity0.04
Current Ratio2.08
Quick Ratio1.68
Book Value/Sh17.73 USD
Cash/Share6.40 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)61.75 USD
Upside (mean)+45.1%
Target Range55.00 USD – 67.00 USD
55.00+45.1% to mean67.00
# Analysts4
Ownership
Shares Out.58.22M
Float51.74M
Insiders4.32%
Institutions106.28%
Short Interest
Short Ratio8.6d
Short % Float10.52%
Short % Out.8.57%
Shares Short4.99M
Short (prev mo.)4.15M
Technical
SMA 5044.73 (-4.8%)
SMA 20048.21 (-11.7%)
Beta0.56
S&P 52W Chg14.58%
Avg Vol (30d)609.64K
Avg Vol (10d)617.41K
Technical Indicators
RSI (14)42.8
MACD-0.6367
MACD Signal-0.7609
MACD Hist.+0.1242
BB Upper44.85 USD
BB Middle42.86 USD
BB Lower40.86 USD
BB Width9.31%
ATR (14)1.479 USD
Vol Ratio (20d)1.20x